Lv1
20 积分 2024-07-15 加入
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1–2 study
22小时前
待确认
Pacritinib (PAC) Synergistically Potentiates Azacitidine (5AZA) Cytotoxicity in Chronic Myelomonocytic Leukemia (CMML)
23小时前
求助中
Interleukin 10 inhibits growth and granulocyte/macrophage colony-stimulating factor production in chronic myelomonocytic leukemia cells
14天前
已完结
A phase 1/2 study of ruxolitinib and decitabine in patients with post-myeloproliferative neoplasm acute myeloid leukemia
17天前
已完结
Clinical Correlates of Venetoclax-Based Combination Sensitivities to Augment Acute Myeloid Leukemia Therapy
17天前
已完结
Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study
18天前
已关闭
Mutations and prognosis in primary myelofibrosis
20天前
已完结
Effective treatment of low-risk acute GVHD with itacitinib monotherapy
23天前
已完结
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
24天前
已完结
Adult Acute Lymphoblastic Leukemia: 2025 Update on Diagnosis, Therapy, and Monitoring
1个月前
已完结
皖公网安备34019202002308
